JP2019527033A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019527033A5 JP2019527033A5 JP2018560082A JP2018560082A JP2019527033A5 JP 2019527033 A5 JP2019527033 A5 JP 2019527033A5 JP 2018560082 A JP2018560082 A JP 2018560082A JP 2018560082 A JP2018560082 A JP 2018560082A JP 2019527033 A5 JP2019527033 A5 JP 2019527033A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- antigen
- binding fragment
- seq
- factor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022090787A JP2022133276A (ja) | 2016-05-16 | 2022-06-03 | 抗第ＩＸ因子Ｐａｄｕａ抗体 |
| JP2024022760A JP7671887B2 (ja) | 2016-05-16 | 2024-02-19 | 抗第ＩＸ因子Ｐａｄｕａ抗体 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662337118P | 2016-05-16 | 2016-05-16 | |
| US62/337,118 | 2016-05-16 | ||
| US201662340834P | 2016-05-24 | 2016-05-24 | |
| US62/340,834 | 2016-05-24 | ||
| PCT/US2017/032808 WO2017200981A1 (en) | 2016-05-16 | 2017-05-16 | Anti-factor ix padua antibodies |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022090787A Division JP2022133276A (ja) | 2016-05-16 | 2022-06-03 | 抗第ＩＸ因子Ｐａｄｕａ抗体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019527033A JP2019527033A (ja) | 2019-09-26 |
| JP2019527033A5 true JP2019527033A5 (enExample) | 2020-06-18 |
| JP7084878B2 JP7084878B2 (ja) | 2022-06-15 |
Family
ID=59067875
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018560082A Active JP7084878B2 (ja) | 2016-05-16 | 2017-05-16 | 抗第ＩＸ因子Ｐａｄｕａ抗体 |
| JP2022090787A Withdrawn JP2022133276A (ja) | 2016-05-16 | 2022-06-03 | 抗第ＩＸ因子Ｐａｄｕａ抗体 |
| JP2024022760A Active JP7671887B2 (ja) | 2016-05-16 | 2024-02-19 | 抗第ＩＸ因子Ｐａｄｕａ抗体 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022090787A Withdrawn JP2022133276A (ja) | 2016-05-16 | 2022-06-03 | 抗第ＩＸ因子Ｐａｄｕａ抗体 |
| JP2024022760A Active JP7671887B2 (ja) | 2016-05-16 | 2024-02-19 | 抗第ＩＸ因子Ｐａｄｕａ抗体 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US11098132B2 (enExample) |
| EP (1) | EP3458477B1 (enExample) |
| JP (3) | JP7084878B2 (enExample) |
| KR (2) | KR102625416B1 (enExample) |
| CN (1) | CN109563154B (enExample) |
| AU (1) | AU2017268198C1 (enExample) |
| CA (1) | CA3024485A1 (enExample) |
| IL (1) | IL262813B2 (enExample) |
| RU (2) | RU2770006C2 (enExample) |
| SG (1) | SG11201809642TA (enExample) |
| WO (1) | WO2017200981A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201709970D0 (en) | 2017-06-22 | 2017-08-09 | Kymab Ltd | Bispecific antigen-binding molecules |
| CN110343181B (zh) * | 2018-04-08 | 2022-04-08 | 苏州康宁杰瑞生物科技有限公司 | 针对凝血因子ix(fix)的单域抗体 |
| ES2901683T3 (es) | 2018-12-21 | 2022-03-23 | Kymab Ltd | Anticuerpo biespecífico FIXAXFX con cadena ligera común |
| GB202009928D0 (en) * | 2020-06-29 | 2020-08-12 | Freeline Therapeutics Ltd | Method |
| KR102749341B1 (ko) * | 2022-07-08 | 2025-01-06 | 노보 노르디스크 에이/에스 | FVIII(a)를 치환할 수 있는 매우 강력한 ISVD 화합물 |
| CN118834275A (zh) * | 2023-02-07 | 2024-10-25 | 湖南九典制药股份有限公司 | 一种抗菌/抗炎多肽及其用途 |
Family Cites Families (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3691016A (en) | 1970-04-17 | 1972-09-12 | Monsanto Co | Process for the preparation of insoluble enzymes |
| CA1023287A (en) | 1972-12-08 | 1977-12-27 | Boehringer Mannheim G.M.B.H. | Process for the preparation of carrier-bound proteins |
| US4195128A (en) | 1976-05-03 | 1980-03-25 | Bayer Aktiengesellschaft | Polymeric carrier bound ligands |
| US4330440A (en) | 1977-02-08 | 1982-05-18 | Development Finance Corporation Of New Zealand | Activated matrix and method of activation |
| CA1093991A (en) | 1977-02-17 | 1981-01-20 | Hideo Hirohara | Enzyme immobilization with pullulan gel |
| US4229537A (en) | 1978-02-09 | 1980-10-21 | New York University | Preparation of trichloro-s-triazine activated supports for coupling ligands |
| GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| US5530101A (en) * | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
| US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
| ES2108048T3 (es) | 1990-08-29 | 1997-12-16 | Genpharm Int | Produccion y utilizacion de animales inferiores transgenicos capaces de producir anticuerpos heterologos. |
| US5780279A (en) | 1990-12-03 | 1998-07-14 | Genentech, Inc. | Method of selection of proteolytic cleavage sites by directed evolution and phagemid display |
| DE69129154T2 (de) | 1990-12-03 | 1998-08-20 | Genentech, Inc., South San Francisco, Calif. | Verfahren zur anreicherung von proteinvarianten mit geänderten bindungseigenschaften |
| US5858657A (en) | 1992-05-15 | 1999-01-12 | Medical Research Council | Methods for producing members of specific binding pairs |
| US5871907A (en) | 1991-05-15 | 1999-02-16 | Medical Research Council | Methods for producing members of specific binding pairs |
| US6225447B1 (en) | 1991-05-15 | 2001-05-01 | Cambridge Antibody Technology Ltd. | Methods for producing members of specific binding pairs |
| US5234784A (en) | 1992-04-01 | 1993-08-10 | Eastman Kodak Company | Method of making a projection viewable transparency comprising an electrostatographic toner image |
| US5639641A (en) | 1992-09-09 | 1997-06-17 | Immunogen Inc. | Resurfacing of rodent antibodies |
| US5855885A (en) | 1993-01-22 | 1999-01-05 | Smith; Rodger | Isolation and production of catalytic antibodies using phage technology |
| WO2002060950A2 (en) | 1994-11-14 | 2002-08-08 | Ludwig Institute For Cancer Research | Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy |
| US5702892A (en) | 1995-05-09 | 1997-12-30 | The United States Of America As Represented By The Department Of Health And Human Services | Phage-display of immunoglobulin heavy chain libraries |
| US6699843B2 (en) | 1995-06-07 | 2004-03-02 | Gilead Sciences, Inc. | Method for treatment of tumors using nucleic acid ligands to PDGF |
| US6265150B1 (en) | 1995-06-07 | 2001-07-24 | Becton Dickinson & Company | Phage antibodies |
| US5714352A (en) | 1996-03-20 | 1998-02-03 | Xenotech Incorporated | Directed switch-mediated DNA recombination |
| DK0826696T3 (da) | 1996-09-03 | 2002-09-23 | Gsf Forschungszentrum Umwelt | Anvendelse af bi- og trispecifikke antistoffer til inducering af en tumorimmunitet |
| US6057098A (en) | 1997-04-04 | 2000-05-02 | Biosite Diagnostics, Inc. | Polyvalent display libraries |
| AT411997B (de) | 1999-09-14 | 2004-08-26 | Baxter Ag | Faktor ix/faktor ixa aktivierende antikörper und antikörper-derivate |
| US20020197266A1 (en) | 2000-02-08 | 2002-12-26 | Waldemar Debinski | Immunotherapy using interleukin 13 receptor subunit alpha 2 |
| US20040096983A1 (en) * | 2002-11-14 | 2004-05-20 | Jacobs Merrit N. | Wash process for a sample being analyzed |
| EP2368578A1 (en) | 2003-01-09 | 2011-09-28 | Macrogenics, Inc. | Identification and engineering of antibodies with variant Fc regions and methods of using same |
| TWI353991B (en) | 2003-05-06 | 2011-12-11 | Syntonix Pharmaceuticals Inc | Immunoglobulin chimeric monomer-dimer hybrids |
| US7297336B2 (en) * | 2003-09-12 | 2007-11-20 | Baxter International Inc. | Factor IXa specific antibodies displaying factor VIIIa like activity |
| WO2005087812A1 (en) | 2004-03-05 | 2005-09-22 | Ludwig Institute For Cancer Research | Multivalent antibody materials and methods for vegf/pdgf family of growth factors |
| EP2824183B1 (en) * | 2005-04-08 | 2020-07-29 | Chugai Seiyaku Kabushiki Kaisha | Methods for producing bispecific antibodies |
| US8234784B2 (en) | 2008-02-13 | 2012-08-07 | Younger Steven W | Valve piston repositioning apparatus and method |
| HK1213521A1 (zh) * | 2012-09-25 | 2016-07-08 | Bioverativ Therapeutics Inc. | Fix多肽的應用 |
| DK2911687T3 (da) | 2012-10-26 | 2019-05-13 | Univ Brussel Vrije | Vektor til levermålrettet genterapi af hæmofili og fremgangsmåder og anvendelse deraf |
| EP2881463A1 (en) | 2013-12-09 | 2015-06-10 | DRK-Blutspendedienst Baden-Württemberg-Hessen gGmbH | Factor IX variants with clotting activity in absence of their cofactor and/or with increased F.IX clotting activity and their use for treating bleeding disorders |
| US11008561B2 (en) * | 2014-06-30 | 2021-05-18 | Bioverativ Therapeutics Inc. | Optimized factor IX gene |
-
2017
- 2017-05-16 RU RU2018138782A patent/RU2770006C2/ru active
- 2017-05-16 CN CN201780044200.9A patent/CN109563154B/zh active Active
- 2017-05-16 CA CA3024485A patent/CA3024485A1/en active Pending
- 2017-05-16 SG SG11201809642TA patent/SG11201809642TA/en unknown
- 2017-05-16 KR KR1020227044875A patent/KR102625416B1/ko active Active
- 2017-05-16 AU AU2017268198A patent/AU2017268198C1/en active Active
- 2017-05-16 WO PCT/US2017/032808 patent/WO2017200981A1/en not_active Ceased
- 2017-05-16 KR KR1020187036234A patent/KR102481704B1/ko active Active
- 2017-05-16 EP EP17730590.1A patent/EP3458477B1/en active Active
- 2017-05-16 JP JP2018560082A patent/JP7084878B2/ja active Active
- 2017-05-16 US US16/301,962 patent/US11098132B2/en active Active
- 2017-05-16 IL IL262813A patent/IL262813B2/en unknown
- 2017-05-16 RU RU2022108606A patent/RU2022108606A/ru unknown
-
2021
- 2021-08-17 US US17/404,459 patent/US11999798B2/en active Active
-
2022
- 2022-06-03 JP JP2022090787A patent/JP2022133276A/ja not_active Withdrawn
-
2024
- 2024-02-19 JP JP2024022760A patent/JP7671887B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019527033A5 (enExample) | ||
| US8618247B2 (en) | Peptide, use of the peptide, method for the production of the peptide, solid support having the peptide immobilized thereon, and method for production of the solid support | |
| JP2002502977A (ja) | マイクロアレイとその使用 | |
| RU2018138782A (ru) | Антитела к фактору ix padua | |
| US20100203653A1 (en) | Protein G-Oligonucleotide Conjugate | |
| CN105473606A (zh) | 具有突变的支架的结合多肽 | |
| EP2588495B1 (en) | Histone citrullinated peptides and uses thereof | |
| JP2004532024A (ja) | タンパク質解析 | |
| CN107110848B (zh) | 以脱氧羟腐胺缩赖氨酸合酶基因作为指标使用的动脉硬化及癌的检测方法 | |
| Tschiggerl et al. | Display of a peptide mimotope on a crystalline bacterial cell surface layer (S-layer) lattice for diagnosis of Epstein–Barr virus infection | |
| CN103797369A (zh) | 抗wt1抗体的测定方法 | |
| US11008365B2 (en) | Polypeptide exhibiting affinity to antibodies forming non-native three-dimensional structure | |
| KR101864375B1 (ko) | 바이오 실리카를 이용한 물질의 검출, 분리 또는 정제 | |
| WO2019081912A1 (en) | ANTIGENS OF THE RECEPTOR OF A2 PHOSPHOLIPASE AND THEIR MEDICAL USE | |
| JP7373993B2 (ja) | 組換えＧｐＩｂα受容体タンパク質を含む組成物 | |
| US20140329706A1 (en) | Affinity tags, and related affinity ligands, engineered proteins, modified supports, compositions, methods and systems | |
| US20130066046A1 (en) | General Method for Generating Ultra-High Affinity Binding Proteins | |
| NZ747752B2 (en) | Anti-factor ix padua antibodies | |
| Anaya et al. | A multiplex extracellular interactome screening method employing high-avidity nanoparticles | |
| US20030049694A1 (en) | Production of fusion proteins and use for identifying binding molecules | |
| CN121627883A (zh) | 一种针对hnl新表位的诊断用单克隆抗体制备及其应用 | |
| WO2021173080A1 (en) | Serological test for zika virus | |
| JPH11287804A (ja) | 免疫測定試薬の製造方法、免疫測定試薬及び免疫測定方法 | |
| CN110437341A (zh) | 一种具有红色荧光活性的检测蛋白及其应用 | |
| WO2004018521A1 (ja) | 抗イディオタイプ抗体、該抗イディオタイプ抗体の作成方法、及び該抗イディオタイプ抗体を用いたイディオタイプ抗体の調製方法 |